Compare CDXS & CTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDXS | CTW |
|---|---|---|
| Founded | 2002 | 2013 |
| Country | United States | Japan |
| Employees | N/A | N/A |
| Industry | Major Chemicals | EDP Services |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.8M | 93.6M |
| IPO Year | 2008 | N/A |
| Metric | CDXS | CTW |
|---|---|---|
| Price | $1.23 | $1.79 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.5M | 45.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.54 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $138,590,000.00 | N/A |
| Revenue This Year | $15.64 | N/A |
| Revenue Next Year | $5.23 | N/A |
| P/E Ratio | ★ N/A | $22.41 |
| Revenue Growth | ★ 32.30 | N/A |
| 52 Week Low | $0.96 | $1.10 |
| 52 Week High | $3.87 | $3.14 |
| Indicator | CDXS | CTW |
|---|---|---|
| Relative Strength Index (RSI) | 49.98 | 56.21 |
| Support Level | $1.17 | $1.19 |
| Resistance Level | $1.24 | $1.77 |
| Average True Range (ATR) | 0.11 | 0.19 |
| MACD | 0.04 | 0.04 |
| Stochastic Oscillator | 81.94 | 66.07 |
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
CTW Cayman operates the web-based HTML5 gaming platform G123.jp, offering free-to-play games based on Japanese animations, including Queen's Blade, So I'm a Spider, So What?, and Goblin Slayer. The platform features 29 games, with 11 in pre-registration. The Group provides a platform for game developers to generate revenue and reach an international audience through shared revenue from players' in-game purchases. It operates in Japan, Singapore, Taiwan, and China, excluding Taiwan, with the majority of revenue derived from Japan, and has one reporting segment focused on game distribution and related services.